Free press releases distribution network?

Agency / Source: Pharma Market Research Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



/RC/ Healthcare and Pharma Experts to Tackle 2013’s Most Critical Issues - Healthcare and pharmaceutical industry leaders are looking toward 2013 as a time of big decisions, many of which will be influenced by the Pharma Market Research Conference - PharmaMarketResearchConference.com
/RC/ Healthcare and Pharma Experts to Tackle 2013’s Most Critical Issues

 

PRZOOM - /newswire/ - East Brunswick, NJ, United States, 2012/07/11 - Healthcare and pharmaceutical industry leaders are looking toward 2013 as a time of big decisions, many of which will be influenced by the Pharma Market Research Conference - PharmaMarketResearchConference.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

For anyone affected by health insurance or prescription drugs, buzz is building for the first major event in 2013 that everyone will be discussing. Healthcare, pharmaceutical, biotechnology, medical devices, and other life sciences professionals all know there is only one place to be on February 5-6, 2013- the Pharma Market Research Conference at the Hilton East Brunswick in East Brunswick, New Jersey.

“I thought the Pharma Market Research conference was a great venue to tap into key trends occurring in our industry, learn of cutting-edge market research approaches and technologies to tackle business challenges, and engage with colleagues in our field. The program and exhibits were excellent,” said a participant from GlaxoSmithKline.

Industry experts will share their knowledge, including thought leaders from Allergan, Alexion, Auxilium, Bayer, Bristol-Myer Squibb, GE Healthcare, Johnson & Johnson, Merck, Novartis, Pfizer, Shionogi, Shire, Takeda, Upsher-Smith, and many more!

The Pharma Market Research Conference is buoyed by an impressive advisory board of clear industry leaders. Advisory board members are helping shape the program agenda to make sure the most critical issues are all covered. Stay tuned for details to be released about the exciting program!

“Great conference! Compelling insights offered by a broad cross-section of Pharma Market Research experts!,” said a participant from AstraZeneca.

“The Pharma Market Research Conference is a terrific opportunity to stay up to date on the latest tools and techniques of our craft. The multi-track system offers flexibility to attend seminars that best meet your needs. And re-connecting with colleagues I haven’t seen in a while was another positive benefit,” said a participant from Johnson & Johnson.

The Pharma Market Research Conference is your EXCLUSIVE ENTRY into the world of pharmaceutical market research. Nowhere else will you find the industry's best and brightest all under one roof! More than 300 people came in 2012. The exhibit space sold out! Feedback has been overwhelmingly positive as 2013 is on track for even more success for all participants.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Pharma Market Research Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


/RC/ Healthcare and Pharma Experts to Tackle 2013’s Most Critical Issues

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: PharmaMarketResearchConference.com 
212-228-7974 info[.]pharmamarketresearchconference.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Pharma Market Research Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Pharma Market Research Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com

Visit  SKS Media | SKS Associates Ltd







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today